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(1) describe results contradicting those in another recent JCI article (2) that concerns the effects of nitric oxide (NO) on hemoglobin (Hb). Before we attempt to dissect the controversy, let us step back a bit. NO is generated from L-arginine by NO synthases (NOSs) that are differentially induced by cell-specific (endothelium, neutrophils, adrenal tissue, cerebellum) cofactors such as Ca 2+ -dependent calmodulin, TNF, and other cytokines (3, 4) . NO physiological activity might involve direct cell-to-cell interaction and be only partially mediated by blood NO. The steady-state level of blood NO is the consequence of a balance between the production of NO by NOSs, the binding or scavenging of NO by Hb, and the transformation of NO into NO 2 -and NO 3 -. NO has an affinity for Hb that is 100 times higher than that of CO and 200,000 times higher than that of O 2 , which has given NO the reputation of being a very toxic compound lacking physiological importance.
Among the functions of NO is the maintenance of vascular tone. Another physiological function might be the formation of S-nitroso Hb, the product of NO -binding to the β93 cysteine. Gow and Stamler (5) propose that S-nitroso Hb generated in the lungs, where Hb is in the oxygenated (R) state, liberates NO in the microcirculation, where the conformational transition (R→T), induced by deoxygenation, liberates NO from the β93Cys site; the NO then acts on subendothelial muscle as a vasodilator. Also, there is crystallographic evidence that NO can bind to β93Cys (6).
The Stamler model, while attractive, leaves several questions unanswered. First, there is no evidence that NO is liberated from the β93Cys site when Hb changes conformation to the T state. Second, as Yakashi Yonetani (personal communication) has pointed out, nitroso compounds do not liberate NO, but rather NO + , which may then be converted into NO. The mechanisms involved in this conversion in the red cell, and the process by which NO + might be exported from the red cell, are not understood. The physiological significance of β93Cys binding of NO requires further research.
Breathing NO raises other issues when considering the clinical applications of NO. Recently, acute-care physicians began using low-concentration gases (generally 5-10 ppm) to manage the acute pulmonary hypertension seen in acute respiratory distress syndrome (ARDS), primary pulmonary hypertension, and bronchospastic disorders. The use of NO is still considered dangerous in sepsis, as a higher production of NO and hypotension is observed in this complication (7) . In animal studies, inhalation of 10-40 ppm of NO for 6 months had no ill effect. The common explanation for this is that rapid binding of NO by Hb mops up this dangerous vasodilator. Indeed, when NO is bound to Hb, the affinity for O 2 is significantly reduced. However, NO binds preferentially to the hemes attached to the α-globin chains, inducing a change of conformation of the Hb molecule to a super-T state (8); this is due to the breaking of the bond between the iron and the proximal histidine. While the hemes that have bound NO are excluded from O 2 exchange, the other 2 remaining hemes now have a particularly low O 2 affinity and can deliver O 2 to the tissues more efficiently than in the normal T state. Hence, although the NO tetramer has fewer ligand-carrying hemes (2 out of 4), it exhibits almost the same efficiency of O 2 delivery as does a normal Hb tetramer. The tetramers containing NO will, in a period of about half an hour, be converted to metHb, lose NO, and be reduced by the metHb reductase system of the red cell into normal Hb. For these reasons, NO at limited concentrations is not as toxic as originally feared.
What is the mechanism of metHb formation in Hb's containing heme-bound NO? The rate of NO-dependent oxidation varies linearly with NO concentration, but not with O 2 concentration (9).
Nonreversible NO binding and NOinduced oxidation occur in 2 steps: (a) bimolecular entry of NO into the distal portion of the heme pocket, and (b) rapid reaction of noncovalently bound NO with iron to produce several iron complexes. This unwelcome effect of NO could be particularly problematic in the sickle cell, which already produces more metHb than normal cells, pushing the reductase systems to its limits.
Returning to the JCI papers, Head et al. (2) stated that their objective was "to determine if low concentrations of NO gas would augment the O 2 affinity of red cells containing homozygous HbS (SS)." Even if it were possible, many believe that this is not a viable strategy to ameliorate sickle cell anemia, as it will only shift the burden of deoxygenation from the high-affinity tetramers to lower-affinity tetramers (which will still be capable of polymerization). Head et al. found that SS red cells, incubated in vitro with varying concentrations of NO (up to 80 ppm for 5 minutes or longer), decreased their P 50 by 15% -a change that was correlated with NO concentration. In contrast, the P 50 of normal red cells was unchanged. Moreover, in SS patients breathing 80 ppm NO for 45 minutes, the P 50 also decreased significantly. Control subjects breathing NO showed no change in P 50 . MetHb remained low in all subjects breathing NO. The authors did not provide an explanation for the left-shifted O 2 equilibrium curve found in SS red cells. It initially seemed likely that this left shift arose because of the wellknown Darling-Roughton effect arising from metHb. According to this effect, when 1 or 2 hemes are either met or CO-bound, the tetramer tends to adopt the R state (high affinity) in the remaining O 2 binding sites (provided that a sufficient number of chains are modified). This mechanism explains the left shift in chronic methemoglobinemia and CO intoxication. Alternatively, it could have been the melting of the sickle polymers, but
